# Allogene Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 29, 2025, 18:11 ET
- Period: 2025-06-18
- Accession: 0001737287-25-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000173728725000049/allo-20250429.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001737287-25-000049. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
